| # | Drug | Count |
|---|---|---|
| 0 | DURVALUMAB | 3 |
| 1 | APIXABAN | 2 |
| 2 | ATENOLOL | 2 |
| 3 | CARBOPLATIN | 2 |
| 4 | ADALIMUMAB | 1 |
| 5 | ALBUTEROL SULFATE | 1 |
| 6 | AMLODIPINE | 1 |
| 7 | BENRALIZUMAB | 1 |
| 8 | CETIIRIZINE | 1 |
| 9 | CETIRIZINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0023 |
| 1 | CROMOLYN SODIUM | 1 | 0.0003 |
| 2 | DURVALUMAB | 3 | 0.0001 |
| 3 | THYROID, PORCINE | 1 | 0.0001 |
| 4 | BENRALIZUMAB | 1 | 0.0000 |
| 5 | MESALAMINE | 1 | 0.0000 |
| 6 | NALTREXONE | 1 | 0.0000 |
| 7 | APIXABAN | 2 | 0.0000 |
| 8 | CETIIRIZINE | 1 | 0.0000 |
| 9 | CARBOPLATIN | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 3 |
| 1 | Corticosteroid [EPC] | 2 |
| 2 | Factor Xa Inhibitor [EPC] | 2 |
| 3 | Platinum-based Drug [EPC] | 2 |
| 4 | beta-Adrenergic Blocker [EPC] | 2 |
| 5 | Aminosalicylate [EPC] | 1 |
| 6 | Anti-IgE [EPC] | 1 |
| 7 | Azole Antifungal [EPC] | 1 |
| 8 | Calcium Channel Blocker [EPC] | 1 |
| 9 | Catecholamine [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 1 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 2 | Catecholamine [EPC] | 1 | 0.0000 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Anti-IgE [EPC] | 1 | 0.0000 |
| 5 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 8 | Factor Xa Inhibitor [EPC] | 2 | 0.0000 |
| 9 | beta-Adrenergic Blocker [EPC] | 2 | 0.0000 |